Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial.
作者信息
Kalil Andre C, Stebbing Justin
机构信息
Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Department of Surgery and Cancer, Imperial College London, London, UK.
出版信息
Lancet Respir Med. 2021 Dec;9(12):1349-1351. doi: 10.1016/S2213-2600(21)00358-1. Epub 2021 Sep 1.
Abstract
摘要
Zotero 插件